HanBio Therapeutics
Shanghai
About HanBio Therapeutics
HanBio Therapeutics is a biotechnology company committed to researching and developing next generation transformative medicines.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $40.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2022)
- Website: hanbiotx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical, Therapeutics
Canonical: https://fsome.com/organization/hanbio-therapeutics-35185 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.